ligand
→
CapableOf
→
disclaim any intent
|
0.68
|
|
ligand
→
CapableOf
→
bind to receptor
|
0.59
|
|
ligand
→
CapableOf
→
act as a lewis base
|
0.54
|
|
ligand
→
CapableOf
→
established multiple alliances
|
0.52
|
|
ligand
→
CapableOf
→
bind to protein
|
0.50
|
|
ligand
→
CapableOf
→
activate receptor
|
0.47
|
|
ligand
→
CapableOf
→
create cash flows
|
0.46
|
|
ligand
→
CapableOf
→
established other business rela…
|
0.42
|
|
ligand
→
CapableOf
→
interact with receptor
|
0.42
|
|
ligand
→
CapableOf
→
established merck
|
0.39
|
|
ligand
→
CapableOf
→
established spectrum pharmaceut…
|
0.39
|
|
ligand
→
CapableOf
→
bind to a central metal atom
|
0.38
|
|
ligand
→
CapableOf
→
established eli lilly
|
0.38
|
|
ligand
→
CapableOf
→
established pfizer
|
0.38
|
|
ligand
→
CapableOf
→
experience delay
|
0.38
|
|
ligand
→
CapableOf
→
attach to metal
|
0.37
|
|
ligand
→
CapableOf
→
bind to polypeptide
|
0.37
|
|
ligand
→
CapableOf
→
form complex
|
0.37
|
|
ligand
→
CapableOf
→
experience significant costs
|
0.37
|
|
ligand
→
CapableOf
→
bind through two sites
|
0.36
|
|
ligand
→
CapableOf
→
induce conformational change
|
0.36
|
|
ligand
→
CapableOf
→
bind to the polymer
|
0.35
|
|
ligand
→
CapableOf
→
receive revenue
|
0.35
|
|
ligand
→
CapableOf
→
vary in size
|
0.35
|
|
ligand
→
CapableOf
→
induce g protein-mediated signa…
|
0.34
|
|
ligand
→
CapableOf
→
bind to tlrs
|
0.30
|
|
ligand
→
CapableOf
→
hold a 1% ownership interest
|
0.30
|
|
ligand
→
CapableOf
→
produce signal
|
0.30
|
|
ligand
→
CapableOf
→
receive a license fee
|
0.30
|
|
ligand
→
CapableOf
→
bind to dna double helix
|
0.28
|
|
ligand
→
CapableOf
→
bind to notch receptors
|
0.28
|
|
ligand
→
CapableOf
→
engage in wrongful acts
|
0.28
|
|
ligand
→
CapableOf
→
exhibit enzymatic properties
|
0.28
|
|
ligand
→
CapableOf
→
induce -arrestin recruitment in…
|
0.28
|
|
ligand
→
CapableOf
→
interact with corresponding mol…
|
0.28
|
|
ligand
→
CapableOf
→
pay 17.5 million
|
0.28
|
|
ligand
→
CapableOf
→
activate rage
|
0.25
|
|
ligand
→
CapableOf
→
bind in alternative binding mode
|
0.25
|
|
ligand
→
CapableOf
→
bind to enzyme
|
0.25
|
|
ligand
→
CapableOf
→
bind to natriuretic peptide
|
0.25
|
|
ligand
→
CapableOf
→
chelate agent
|
0.25
|
|
ligand
→
CapableOf
→
comprise two major specificity …
|
0.25
|
|
ligand
→
CapableOf
→
dictate ligand substitution rat…
|
0.25
|
|
ligand
→
CapableOf
→
dictate the reactivity of the l…
|
0.25
|
|
ligand
→
CapableOf
→
established astrazeneca
|
0.25
|
|
ligand
→
CapableOf
→
established bristol-myers squibb
|
0.25
|
|
ligand
→
CapableOf
→
expect to enter into warrant tr…
|
0.25
|
|
ligand
→
CapableOf
→
form octahedron
|
0.25
|
|
ligand
→
CapableOf
→
fund as part of the agreement
|
0.25
|
|
ligand
→
CapableOf
→
induce change
|
0.25
|
|
ligand
→
CapableOf
→
interact with domain
|
0.25
|
|
ligand
→
CapableOf
→
interact with structure
|
0.25
|
|
ligand
→
CapableOf
→
receive an ownership position
|
0.25
|
|
ligand
→
CapableOf
→
reserved such shares of common …
|
0.25
|
|
ligand
→
CapableOf
→
earned a $1.5 million milestone…
|
0.16
|
|
ligand
→
CapableOf
→
expend significant resources
|
0.16
|
|
ligand
→
CapableOf
→
interfere with current conducti…
|
0.16
|
|